Kornitzer Capital Management Inc Charles River Laboratories International, Inc. Transaction History

Kornitzer Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$197.11 - $250.07 $5.16 Million - $6.55 Million	-26,176 Reduced 41.57%	36,800 $8.02 Million
Q3 2022 Nov 03, 2022	SELL	$182.44 - $250.54 $627,411 - $861,607	-3,439 Reduced 5.18%	62,976 $12.4 Million
Q3 2021 Nov 03, 2021	SELL	$372.64 - $458.3 $3.19 Million - $3.92 Million	-8,560 Reduced 11.42%	66,415 $27.4 Million
Q1 2021 Apr 30, 2021	BUY	$249.67 - $299.48 $9.18 Million - $11 Million	36,775 Added 96.27%	74,975 $21.7 Million
Q4 2020 Jan 29, 2021	BUY	$222.0 - $252.62 $8.48 Million - $9.65 Million	38,200 New	38,200 $9.55 Million

694

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.